Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
FBP1 controls liver cancer evolution from senescent MASH hepatocytes
Li Gu, Yahui Zhu, Shuvro P. Nandi, Maiya Lee, Kosuke Watari, Breanna Bareng, Masafumi Ohira, Yuxiao Liu, Sadatsugu Sakane, Rodrigo Carlessi, Consuelo Sauceda, Debanjan Dhar, Souradipta Ganguly, Mojgan Hosseini, Marcos G. Teneche, Peter D. Adams, David J. Gonzalez, Tatiana Kisseleva, Janina E. E. Tirnitz‐Parker, Peter J. Leedman, M. Christopher Wallace, Louise N Winteringham, Benjamin J. Dwyer, Jonathan Tibballs, Kim W. Carter, Alistair R. R. Forrest, Janina E. E. Tirnitz‐Parker, M. Celeste Simon, Ludmil B. Alexandrov, Michael Karin (2025). FBP1 controls liver cancer evolution from senescent MASH hepatocytes. , 637(8045), DOI: https://doi.org/10.1038/s41586-024-08317-9.
Article52 days agoAuthor Correction: FBP1 controls liver cancer evolution from senescent MASH hepatocytes
Li Gu, Yahui Zhu, Shuvro P. Nandi, Maiya Lee, Kosuke Watari, Breanna Bareng, Masafumi Ohira, Yuxiao Liu, Sadatsugu Sakane, Rodrigo Carlessi, Consuelo Sauceda, Debanjan Dhar, Souradipta Ganguly, Mojgan Hosseini, Marcos G. Teneche, Peter D. Adams, David J. Gonzalez, Tatiana Kisseleva, Peter J. Leedman, M. Christopher Wallace, Louise N Winteringham, Benjamin J. Dwyer, Jonathan Tibballs, Kim W. Carter, Alistair R. R. Forrest, M. Celeste Simon, Ludmil B. Alexandrov, Michael Karin (2025). Author Correction: FBP1 controls liver cancer evolution from senescent MASH hepatocytes. , 638 (8051), DOI: https://doi.org/10.1038/s41586-025-08653-4.
Corrigendum52 days agoTherapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC
Ebru Boslem, Saskia Reibe, Rodrigo Carlessi, Benoit Smeuninx, Surafel Tegegne, Casey L. Egan, Emma McLennan, Lauren V. Terry, Max Nobis, Andre Mu, Cameron J. Nowell, N. U. Horadagoda, Darren C. Henstridge, Natalie A. Mellett, Paul Timpson, Matthew F. Jones, Elena Denisenko, Alistair R. R. Forrest, Janina E. E. Tirnitz‐Parker, Peter J. Meikle, Stefan Rose‐John, Michael Karin, Mark A. Febbraio (2023). Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC. , 9(37), DOI: https://doi.org/10.1126/sciadv.adh0831.
Article52 days agoSingle-nucleus RNA sequencing of pre-malignant liver reveals disease-associated hepatocyte state with HCC prognostic potential
Rodrigo Carlessi, Elena Denisenko, Ebru Boslem, Julia Köhn‐Gaone, Nathan Main, N. Dianah B. Abu Bakar, Gayatri D. Shirolkar, Matthew Jones, Aaron B. Beasley, Daniel Poppe, Benjamin J. Dwyer, Connie Jackaman, M. Christian Tjiam, Ryan Lister, Michael Karin, Jonathan Fallowfield, Timothy J. Kendall, Stuart J. Forbes, Elin S. Gray, John K. Olynyk, George C. Yeoh, Alistair R. R. Forrest, Grant A. Ramm, Mark A. Febbraio, Janina E. E. Tirnitz‐Parker (2023). Single-nucleus RNA sequencing of pre-malignant liver reveals disease-associated hepatocyte state with HCC prognostic potential. , 3(5), DOI: https://doi.org/10.1016/j.xgen.2023.100301.
Article52 days agoTherapeutic Blockade of ER Stress and Inflammation Prevents High Fat Diet-Induced NASH and Progression to Hepatocellular Carcinoma
Ebru Boslem, Saskia Riebe, Benoit Smeuninx, Casey L. Egan, Surafel Tegegne, Emma McLennan, Max Nobis, Andre Mu, Cameron J. Nowell, N. U. Horadagoda, Natalie A. Mellet, Rodrigo Carlessi, Paul Timpson, Janina E. E. Tirnitz‐Parker, Peter J. Meikle, Stefan Rose‐John, Michael Karin, Mark A. Febbraio (2022). Therapeutic Blockade of ER Stress and Inflammation Prevents High Fat Diet-Induced NASH and Progression to Hepatocellular Carcinoma. , DOI: https://doi.org/10.2139/ssrn.4001943.
Article52 days ago